

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.37910714 |
| 2 | negative T cell selection (GO:0043383) | 6.24851653 |
| 3 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.23200572 |
| 4 | negative thymic T cell selection (GO:0045060) | 6.15484948 |
| 5 | tolerance induction (GO:0002507) | 6.07952497 |
| 6 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.04138107 |
| 7 | negative regulation of cell killing (GO:0031342) | 6.04138107 |
| 8 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 5.93977825 |
| 9 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.78701755 |
| 10 | regulation of regulatory T cell differentiation (GO:0045589) | 5.45376253 |
| 11 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.21697809 |
| 12 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.11581145 |
| 13 | response to interleukin-15 (GO:0070672) | 5.02329050 |
| 14 | T cell migration (GO:0072678) | 4.82699911 |
| 15 | cellular response to interleukin-15 (GO:0071350) | 4.82575201 |
| 16 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.78721460 |
| 17 | activated T cell proliferation (GO:0050798) | 4.73837595 |
| 18 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.71099668 |
| 19 | thymic T cell selection (GO:0045061) | 4.68238364 |
| 20 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.62573157 |
| 21 | positive regulation of granulocyte differentiation (GO:0030854) | 4.61717427 |
| 22 | T cell selection (GO:0045058) | 4.53388398 |
| 23 | regulation of T cell tolerance induction (GO:0002664) | 4.53354581 |
| 24 | leukocyte aggregation (GO:0070486) | 4.50091104 |
| 25 | regulation of gamma-delta T cell activation (GO:0046643) | 4.49314689 |
| 26 | neutrophil activation involved in immune response (GO:0002283) | 4.33315091 |
| 27 | regulation of alpha-beta T cell proliferation (GO:0046640) | 4.23544122 |
| 28 | positive T cell selection (GO:0043368) | 4.21900641 |
| 29 | positive regulation of tolerance induction (GO:0002645) | 4.16487891 |
| 30 | negative regulation of T cell mediated immunity (GO:0002710) | 4.13633158 |
| 31 | regulation of isotype switching to IgG isotypes (GO:0048302) | 4.12368187 |
| 32 | positive thymic T cell selection (GO:0045059) | 4.12274620 |
| 33 | mast cell activation (GO:0045576) | 3.96837712 |
| 34 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.95941242 |
| 35 | regulation of tolerance induction (GO:0002643) | 3.92939892 |
| 36 | positive regulation of B cell differentiation (GO:0045579) | 3.86499516 |
| 37 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.86323362 |
| 38 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 3.82290672 |
| 39 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.81104341 |
| 40 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.81104341 |
| 41 | positive regulation of interleukin-4 production (GO:0032753) | 3.74761305 |
| 42 | T cell receptor signaling pathway (GO:0050852) | 3.74290096 |
| 43 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.71993754 |
| 44 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.67608469 |
| 45 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.61887602 |
| 46 | positive regulation of T cell differentiation in thymus (GO:0033089) | 3.57739785 |
| 47 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.49295091 |
| 48 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.44155017 |
| 49 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.42704891 |
| 50 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.42069620 |
| 51 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.42068741 |
| 52 | regulation of B cell differentiation (GO:0045577) | 3.41919707 |
| 53 | neutrophil activation (GO:0042119) | 3.36189267 |
| 54 | T cell costimulation (GO:0031295) | 3.35699325 |
| 55 | B cell receptor signaling pathway (GO:0050853) | 3.35171405 |
| 56 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.34609233 |
| 57 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.33463347 |
| 58 | positive regulation of macrophage differentiation (GO:0045651) | 3.32169003 |
| 59 | lymphocyte costimulation (GO:0031294) | 3.31397049 |
| 60 | leukocyte degranulation (GO:0043299) | 3.29306998 |
| 61 | cellular extravasation (GO:0045123) | 3.25967084 |
| 62 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.25695516 |
| 63 | dendritic cell chemotaxis (GO:0002407) | 3.25654631 |
| 64 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.25075627 |
| 65 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.25075627 |
| 66 | type I interferon signaling pathway (GO:0060337) | 3.21669832 |
| 67 | cellular response to type I interferon (GO:0071357) | 3.21669832 |
| 68 | regulation of interleukin-4 production (GO:0032673) | 3.20677886 |
| 69 | T cell homeostasis (GO:0043029) | 3.19577498 |
| 70 | response to type I interferon (GO:0034340) | 3.19216449 |
| 71 | regulation of defense response to virus by virus (GO:0050690) | 3.17796646 |
| 72 | negative regulation of T cell apoptotic process (GO:0070233) | 3.15644326 |
| 73 | detection of bacterium (GO:0016045) | 3.14631669 |
| 74 | mast cell degranulation (GO:0043303) | 3.14230588 |
| 75 | mast cell activation involved in immune response (GO:0002279) | 3.14230588 |
| 76 | positive regulation of isotype switching (GO:0045830) | 3.13910631 |
| 77 | negative regulation of stress fiber assembly (GO:0051497) | 3.09962849 |
| 78 | lymphocyte migration (GO:0072676) | 3.08136038 |
| 79 | alpha-beta T cell differentiation (GO:0046632) | 3.04263853 |
| 80 | positive regulation of interleukin-2 production (GO:0032743) | 3.03965698 |
| 81 | positive regulation of T cell mediated immunity (GO:0002711) | 3.03371103 |
| 82 | detection of other organism (GO:0098543) | 3.02923920 |
| 83 | regulation of granulocyte differentiation (GO:0030852) | 3.02259124 |
| 84 | alpha-beta T cell activation (GO:0046631) | 3.02059688 |
| 85 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.01648318 |
| 86 | positive regulation of cell killing (GO:0031343) | 3.00050463 |
| 87 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.99889023 |
| 88 | dendritic cell migration (GO:0036336) | 2.99546871 |
| 89 | regulation of isotype switching (GO:0045191) | 2.99372092 |
| 90 | interferon-gamma production (GO:0032609) | 2.98706360 |
| 91 | immunoglobulin mediated immune response (GO:0016064) | 2.96870300 |
| 92 | granulocyte activation (GO:0036230) | 2.94775792 |
| 93 | regulation of T cell cytokine production (GO:0002724) | 2.93989503 |
| 94 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.93646896 |
| 95 | regulation of T cell mediated immunity (GO:0002709) | 2.93125256 |
| 96 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.92826410 |
| 97 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 2.92615642 |
| 98 | regulation of cell killing (GO:0031341) | 2.91737063 |
| 99 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.88802603 |
| 100 | positive regulation of B cell mediated immunity (GO:0002714) | 2.88802603 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 6.44760243 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 6.03541715 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.82103640 |
| 4 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.75477394 |
| 5 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.69329155 |
| 6 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.42005860 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.40775398 |
| 8 | MYB_26560356_Chip-Seq_TH2_Human | 3.28350999 |
| 9 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.23094274 |
| 10 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.03207764 |
| 11 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 3.01401694 |
| 12 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.90300085 |
| 13 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.83236661 |
| 14 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.78674274 |
| 15 | MAF_26560356_Chip-Seq_TH1_Human | 2.63028730 |
| 16 | UTX_26944678_Chip-Seq_JUKART_Human | 2.62998752 |
| 17 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.62179561 |
| 18 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.61447982 |
| 19 | MYB_26560356_Chip-Seq_TH1_Human | 2.58428278 |
| 20 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.44646932 |
| 21 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.39194548 |
| 22 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.32107841 |
| 23 | GATA3_27048872_Chip-Seq_THYMUS_Human | 2.28118508 |
| 24 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.27146379 |
| 25 | MYC_22102868_ChIP-Seq_BL_Human | 2.26931095 |
| 26 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.26886448 |
| 27 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.24691153 |
| 28 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.24326820 |
| 29 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.23450904 |
| 30 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.12251138 |
| 31 | SPI1_23127762_ChIP-Seq_K562_Human | 2.05683891 |
| 32 | MAF_26560356_Chip-Seq_TH2_Human | 2.04884898 |
| 33 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 2.00668096 |
| 34 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.91430317 |
| 35 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.83742731 |
| 36 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.80934506 |
| 37 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.79214637 |
| 38 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.78275383 |
| 39 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.78150572 |
| 40 | GATA3_26560356_Chip-Seq_TH2_Human | 1.76542135 |
| 41 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.75269573 |
| 42 | GATA1_22025678_ChIP-Seq_K562_Human | 1.71267027 |
| 43 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.71027811 |
| 44 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.66648145 |
| 45 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.66644743 |
| 46 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.59123356 |
| 47 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.57796993 |
| 48 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.52207702 |
| 49 | GATA1_19941826_ChIP-Seq_K562_Human | 1.52192162 |
| 50 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.49153982 |
| 51 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.48701246 |
| 52 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.45483141 |
| 53 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.41798856 |
| 54 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.39550886 |
| 55 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.34584108 |
| 56 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.32838276 |
| 57 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.26819966 |
| 58 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22726015 |
| 59 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.22437053 |
| 60 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.21198302 |
| 61 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.20468953 |
| 62 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.18437151 |
| 63 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.17887129 |
| 64 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.15996987 |
| 65 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.15832032 |
| 66 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.14956884 |
| 67 | GATA2_19941826_ChIP-Seq_K562_Human | 1.13955532 |
| 68 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.12506449 |
| 69 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.11785920 |
| 70 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.11760901 |
| 71 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.10275986 |
| 72 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.09583250 |
| 73 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.07779696 |
| 74 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.06147978 |
| 75 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.05773190 |
| 76 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.04789712 |
| 77 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.01710503 |
| 78 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.99866065 |
| 79 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.99343963 |
| 80 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97676309 |
| 81 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95624481 |
| 82 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.95374893 |
| 83 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.94296844 |
| 84 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.92724717 |
| 85 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.90617949 |
| 86 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.89829038 |
| 87 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.89315086 |
| 88 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.89068785 |
| 89 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.88104297 |
| 90 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.87673211 |
| 91 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.87438276 |
| 92 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.85439448 |
| 93 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.84832923 |
| 94 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.84672966 |
| 95 | GATA3_26560356_Chip-Seq_TH1_Human | 0.83564448 |
| 96 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.81101104 |
| 97 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.78156406 |
| 98 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.78039527 |
| 99 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.77709547 |
| 100 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.76663624 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003763_abnormal_thymus_physiology | 4.76243050 |
| 2 | MP0005671_abnormal_response_to | 4.33321788 |
| 3 | MP0005464_abnormal_platelet_physiology | 3.98348195 |
| 4 | MP0001835_abnormal_antigen_presentation | 3.81572195 |
| 5 | MP0003724_increased_susceptibility_to | 3.58033591 |
| 6 | MP0003436_decreased_susceptibility_to | 3.51451888 |
| 7 | MP0001800_abnormal_humoral_immune | 3.18433524 |
| 8 | MP0005000_abnormal_immune_tolerance | 3.13693029 |
| 9 | MP0009333_abnormal_splenocyte_physiolog | 2.78763320 |
| 10 | MP0002723_abnormal_immune_serum | 2.74785568 |
| 11 | MP0005387_immune_system_phenotype | 2.74032822 |
| 12 | MP0001790_abnormal_immune_system | 2.74032822 |
| 13 | MP0002420_abnormal_adaptive_immunity | 2.69871151 |
| 14 | MP0001819_abnormal_immune_cell | 2.65463406 |
| 15 | MP0000685_abnormal_immune_system | 2.61064370 |
| 16 | MP0002148_abnormal_hypersensitivity_rea | 2.58491035 |
| 17 | MP0005025_abnormal_response_to | 2.57677375 |
| 18 | MP0002452_abnormal_antigen_presenting | 2.54110808 |
| 19 | MP0002398_abnormal_bone_marrow | 2.53952923 |
| 20 | MP0009785_altered_susceptibility_to | 2.51706268 |
| 21 | MP0000465_gastrointestinal_hemorrhage | 2.48646055 |
| 22 | MP0010155_abnormal_intestine_physiology | 2.42174282 |
| 23 | MP0003866_abnormal_defecation | 2.35505375 |
| 24 | MP0003303_peritoneal_inflammation | 2.34177603 |
| 25 | MP0001873_stomach_inflammation | 2.33877541 |
| 26 | MP0000703_abnormal_thymus_morphology | 2.33104258 |
| 27 | MP0002419_abnormal_innate_immunity | 2.27728378 |
| 28 | MP0002405_respiratory_system_inflammati | 2.27241027 |
| 29 | MP0000716_abnormal_immune_system | 2.21436145 |
| 30 | MP0003300_gastrointestinal_ulcer | 2.11388580 |
| 31 | MP0000689_abnormal_spleen_morphology | 1.99786809 |
| 32 | MP0002722_abnormal_immune_system | 1.98556288 |
| 33 | MP0004947_skin_inflammation | 1.94615089 |
| 34 | MP0001851_eye_inflammation | 1.93234067 |
| 35 | MP0002429_abnormal_blood_cell | 1.81227287 |
| 36 | MP0004381_abnormal_hair_follicle | 1.79421101 |
| 37 | MP0001845_abnormal_inflammatory_respons | 1.73531326 |
| 38 | MP0006082_CNS_inflammation | 1.68415458 |
| 39 | MP0001533_abnormal_skeleton_physiology | 1.64794481 |
| 40 | MP0005310_abnormal_salivary_gland | 1.50779424 |
| 41 | MP0008004_abnormal_stomach_pH | 1.49574374 |
| 42 | MP0002166_altered_tumor_susceptibility | 1.38955890 |
| 43 | MP0005075_abnormal_melanosome_morpholog | 1.36712057 |
| 44 | MP0004510_myositis | 1.34065168 |
| 45 | MP0000858_altered_metastatic_potential | 1.30875043 |
| 46 | MP0000490_abnormal_crypts_of | 1.23760739 |
| 47 | MP0002132_abnormal_respiratory_system | 1.23124311 |
| 48 | MP0008469_abnormal_protein_level | 1.22406594 |
| 49 | MP0002396_abnormal_hematopoietic_system | 1.20484264 |
| 50 | MP0002277_abnormal_respiratory_mucosa | 1.13211777 |
| 51 | MP0009763_increased_sensitivity_to | 1.11912876 |
| 52 | MP0003183_abnormal_peptide_metabolism | 1.08355838 |
| 53 | MP0001663_abnormal_digestive_system | 1.07986567 |
| 54 | MP0004130_abnormal_muscle_cell | 1.05417142 |
| 55 | MP0009278_abnormal_bone_marrow | 1.04404552 |
| 56 | MP0002138_abnormal_hepatobiliary_system | 1.04033088 |
| 57 | MP0009764_decreased_sensitivity_to | 1.02863020 |
| 58 | MP0005451_abnormal_body_composition | 1.02732590 |
| 59 | MP0003828_pulmonary_edema | 1.01976673 |
| 60 | MP0003191_abnormal_cellular_cholesterol | 1.00747398 |
| 61 | MP0008260_abnormal_autophagy | 0.98857847 |
| 62 | MP0002933_joint_inflammation | 0.96077504 |
| 63 | MP0002998_abnormal_bone_remodeling | 0.91487585 |
| 64 | MP0002006_tumorigenesis | 0.89672750 |
| 65 | MP0001348_abnormal_lacrimal_gland | 0.87002246 |
| 66 | MP0003172_abnormal_lysosome_physiology | 0.85679040 |
| 67 | MP0002163_abnormal_gland_morphology | 0.84225878 |
| 68 | MP0009765_abnormal_xenobiotic_induced | 0.82465303 |
| 69 | MP0003045_fibrosis | 0.80161725 |
| 70 | MP0002019_abnormal_tumor_incidence | 0.76518929 |
| 71 | MP0000343_altered_response_to | 0.76374397 |
| 72 | MP0000249_abnormal_blood_vessel | 0.72862596 |
| 73 | MP0001853_heart_inflammation | 0.72611177 |
| 74 | MP0004808_abnormal_hematopoietic_stem | 0.72370881 |
| 75 | MP0002693_abnormal_pancreas_physiology | 0.69396413 |
| 76 | MP0002009_preneoplasia | 0.69252263 |
| 77 | MP0005397_hematopoietic_system_phenotyp | 0.64790640 |
| 78 | MP0001545_abnormal_hematopoietic_system | 0.64790640 |
| 79 | MP0003448_altered_tumor_morphology | 0.62054314 |
| 80 | MP0005166_decreased_susceptibility_to | 0.60686934 |
| 81 | MP0005381_digestive/alimentary_phenotyp | 0.60203359 |
| 82 | MP0008569_lethality_at_weaning | 0.58590927 |
| 83 | MP0008874_decreased_physiological_sensi | 0.57782180 |
| 84 | MP0005083_abnormal_biliary_tract | 0.57101450 |
| 85 | MP0001765_abnormal_ion_homeostasis | 0.56443772 |
| 86 | MP0005390_skeleton_phenotype | 0.56377991 |
| 87 | MP0003091_abnormal_cell_migration | 0.54900490 |
| 88 | MP0009642_abnormal_blood_homeostasis | 0.52836694 |
| 89 | MP0003795_abnormal_bone_structure | 0.51686438 |
| 90 | MP0008961_abnormal_basal_metabolism | 0.50409123 |
| 91 | MP0004883_abnormal_blood_vessel | 0.49838776 |
| 92 | MP0008872_abnormal_physiological_respon | 0.49708308 |
| 93 | MP0005058_abnormal_lysosome_morphology | 0.48536550 |
| 94 | MP0001919_abnormal_reproductive_system | 0.48079809 |
| 95 | MP0000015_abnormal_ear_pigmentation | 0.47652034 |
| 96 | MP0003638_abnormal_response/metabolism_ | 0.42744885 |
| 97 | MP0009840_abnormal_foam_cell | 0.42139062 |
| 98 | MP0000230_abnormal_systemic_arterial | 0.41389128 |
| 99 | MP0002136_abnormal_kidney_physiology | 0.39712528 |
| 100 | MP0005410_abnormal_fertilization | 0.39220489 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Stomatitis (HP:0010280) | 6.17671930 |
| 2 | Prolonged bleeding time (HP:0003010) | 6.15015002 |
| 3 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.43732581 |
| 4 | T lymphocytopenia (HP:0005403) | 5.31939305 |
| 5 | Eczematoid dermatitis (HP:0000976) | 5.29310995 |
| 6 | Abnormality of T cell number (HP:0011839) | 5.04133432 |
| 7 | Autoimmune hemolytic anemia (HP:0001890) | 5.01412020 |
| 8 | Petechiae (HP:0000967) | 4.83177235 |
| 9 | Myositis (HP:0100614) | 4.67140694 |
| 10 | Epistaxis (HP:0000421) | 4.60140859 |
| 11 | Abnormal platelet volume (HP:0011876) | 4.40027186 |
| 12 | Increased IgM level (HP:0003496) | 4.28998483 |
| 13 | Purpura (HP:0000979) | 4.20470234 |
| 14 | Spontaneous hematomas (HP:0007420) | 4.18252482 |
| 15 | Abnormality of T cells (HP:0002843) | 4.17335636 |
| 16 | Gingival bleeding (HP:0000225) | 4.04226569 |
| 17 | Panhypogammaglobulinemia (HP:0003139) | 4.02625204 |
| 18 | Menorrhagia (HP:0000132) | 4.02331653 |
| 19 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.00038748 |
| 20 | Retrobulbar optic neuritis (HP:0100654) | 3.96120880 |
| 21 | Optic neuritis (HP:0100653) | 3.96120880 |
| 22 | Increased mean platelet volume (HP:0011877) | 3.91135831 |
| 23 | Recurrent fungal infections (HP:0002841) | 3.87637853 |
| 24 | Encephalitis (HP:0002383) | 3.85821153 |
| 25 | Orchitis (HP:0100796) | 3.82598115 |
| 26 | Severe combined immunodeficiency (HP:0004430) | 3.79956605 |
| 27 | Recurrent abscess formation (HP:0002722) | 3.79530098 |
| 28 | Abnormality of macrophages (HP:0004311) | 3.75903716 |
| 29 | Recurrent bacterial skin infections (HP:0005406) | 3.74031787 |
| 30 | IgG deficiency (HP:0004315) | 3.73523222 |
| 31 | Meningitis (HP:0001287) | 3.45513508 |
| 32 | Vasculitis (HP:0002633) | 3.44014417 |
| 33 | Pustule (HP:0200039) | 3.36620471 |
| 34 | Joint swelling (HP:0001386) | 3.32166900 |
| 35 | Granulocytopenia (HP:0001913) | 3.31247632 |
| 36 | Obstructive lung disease (HP:0006536) | 3.27108999 |
| 37 | Chronic obstructive pulmonary disease (HP:0006510) | 3.27108999 |
| 38 | Leukocytosis (HP:0001974) | 3.19739373 |
| 39 | IgM deficiency (HP:0002850) | 3.17477390 |
| 40 | Abnormality of T cell physiology (HP:0011840) | 3.14276939 |
| 41 | Lymphopenia (HP:0001888) | 3.13461308 |
| 42 | Recurrent viral infections (HP:0004429) | 3.11814439 |
| 43 | Hyperlipoproteinemia (HP:0010980) | 3.10322203 |
| 44 | Increased IgE level (HP:0003212) | 3.07395408 |
| 45 | Eosinophilia (HP:0001880) | 3.06878552 |
| 46 | Abnormality of eosinophils (HP:0001879) | 3.06130988 |
| 47 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.04216815 |
| 48 | Recurrent cutaneous fungal infections (HP:0011370) | 3.04216815 |
| 49 | Mediastinal lymphadenopathy (HP:0100721) | 3.02026529 |
| 50 | Recurrent bronchitis (HP:0002837) | 2.97109393 |
| 51 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.95453595 |
| 52 | Gastrointestinal infarctions (HP:0005244) | 2.94582810 |
| 53 | Combined immunodeficiency (HP:0005387) | 2.92294796 |
| 54 | Keratoconjunctivitis sicca (HP:0001097) | 2.89565214 |
| 55 | Agammaglobulinemia (HP:0004432) | 2.80964942 |
| 56 | Pulmonary infiltrates (HP:0002113) | 2.78718127 |
| 57 | Recurrent skin infections (HP:0001581) | 2.77574152 |
| 58 | Keratoconjunctivitis (HP:0001096) | 2.75082227 |
| 59 | Hypochromic anemia (HP:0001931) | 2.73018791 |
| 60 | Abnormality of B cell number (HP:0010975) | 2.71947987 |
| 61 | Hypergammaglobulinemia (HP:0010702) | 2.71705381 |
| 62 | Chronic diarrhea (HP:0002028) | 2.70942542 |
| 63 | Inflammation of the large intestine (HP:0002037) | 2.68398972 |
| 64 | Chest pain (HP:0100749) | 2.67830512 |
| 65 | Gastrointestinal inflammation (HP:0004386) | 2.57050349 |
| 66 | Chronic otitis media (HP:0000389) | 2.53344141 |
| 67 | Pulmonary embolism (HP:0002204) | 2.51220724 |
| 68 | B lymphocytopenia (HP:0010976) | 2.47980942 |
| 69 | Impaired platelet aggregation (HP:0003540) | 2.41326126 |
| 70 | Abnormal platelet function (HP:0011869) | 2.41326126 |
| 71 | Hypochromic microcytic anemia (HP:0004840) | 2.39203051 |
| 72 | Arterial thrombosis (HP:0004420) | 2.35250058 |
| 73 | Microcytic anemia (HP:0001935) | 2.33203356 |
| 74 | Urticaria (HP:0001025) | 2.32480887 |
| 75 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.31100753 |
| 76 | Hemoptysis (HP:0002105) | 2.30960408 |
| 77 | Papilloma (HP:0012740) | 2.27091320 |
| 78 | Verrucae (HP:0200043) | 2.27091320 |
| 79 | Anorexia (HP:0002039) | 2.26604310 |
| 80 | Lymphoma (HP:0002665) | 2.24540199 |
| 81 | Episodic fever (HP:0001954) | 2.23275957 |
| 82 | Abnormality of the prostate (HP:0008775) | 2.23128331 |
| 83 | Papilledema (HP:0001085) | 2.21500688 |
| 84 | Autoimmune thrombocytopenia (HP:0001973) | 2.18997344 |
| 85 | Acute hepatic failure (HP:0006554) | 2.14640152 |
| 86 | Gingivitis (HP:0000230) | 2.10527630 |
| 87 | Gangrene (HP:0100758) | 2.10041163 |
| 88 | Thyroiditis (HP:0100646) | 2.09282699 |
| 89 | Hypoproteinemia (HP:0003075) | 2.05248491 |
| 90 | Gastrointestinal stroma tumor (HP:0100723) | 2.03614809 |
| 91 | Abnormal pupillary function (HP:0007686) | 2.02730163 |
| 92 | Polyneuropathy (HP:0001271) | 2.00846264 |
| 93 | Hepatosplenomegaly (HP:0001433) | 1.98048966 |
| 94 | Colitis (HP:0002583) | 1.97920931 |
| 95 | Cellulitis (HP:0100658) | 1.96330917 |
| 96 | IgA deficiency (HP:0002720) | 1.93442122 |
| 97 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.92895077 |
| 98 | Recurrent sinusitis (HP:0011108) | 1.92415537 |
| 99 | Arthralgia (HP:0002829) | 1.91963827 |
| 100 | Nasal polyposis (HP:0100582) | 1.91068908 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.36720855 |
| 2 | TXK | 4.33301015 |
| 3 | RIPK4 | 3.48306993 |
| 4 | FES | 3.30903179 |
| 5 | BTK | 2.91633310 |
| 6 | TAOK3 | 2.80539539 |
| 7 | ZAP70 | 2.77345136 |
| 8 | PRPF4B | 2.50831608 |
| 9 | ITK | 2.46791772 |
| 10 | GRK6 | 2.41414007 |
| 11 | CSK | 2.24826030 |
| 12 | SYK | 2.20092240 |
| 13 | TEC | 2.18059326 |
| 14 | MST4 | 2.15579742 |
| 15 | TYK2 | 2.07238652 |
| 16 | TNK2 | 1.98490032 |
| 17 | SIK3 | 1.95124958 |
| 18 | HCK | 1.94300640 |
| 19 | NLK | 1.88133470 |
| 20 | JAK3 | 1.86095181 |
| 21 | IKBKE | 1.85234362 |
| 22 | LCK | 1.82878658 |
| 23 | CSF1R | 1.58783467 |
| 24 | IRAK4 | 1.57708253 |
| 25 | JAK1 | 1.57366230 |
| 26 | PASK | 1.54091024 |
| 27 | PIK3CG | 1.52437110 |
| 28 | LYN | 1.50232192 |
| 29 | MAP3K13 | 1.42170301 |
| 30 | BLK | 1.42101741 |
| 31 | FGFR4 | 1.39506096 |
| 32 | TBK1 | 1.36176411 |
| 33 | MAP2K3 | 1.26972504 |
| 34 | CAMKK2 | 1.26405101 |
| 35 | EPHB1 | 1.21106867 |
| 36 | CAMKK1 | 1.15102153 |
| 37 | TYRO3 | 1.12437343 |
| 38 | IKBKB | 1.11879128 |
| 39 | BMX | 1.06563092 |
| 40 | MARK3 | 1.05778917 |
| 41 | RIPK1 | 1.04048358 |
| 42 | MAP3K14 | 1.02050982 |
| 43 | IRAK1 | 1.00091530 |
| 44 | MAP3K11 | 0.99375480 |
| 45 | JAK2 | 0.97794146 |
| 46 | PRKCQ | 0.96072895 |
| 47 | FGFR3 | 0.94910235 |
| 48 | PDK1 | 0.92986541 |
| 49 | TESK2 | 0.90412777 |
| 50 | MAPK11 | 0.90046863 |
| 51 | TAOK1 | 0.89440348 |
| 52 | FGR | 0.87253849 |
| 53 | MAP3K3 | 0.83388460 |
| 54 | PIM1 | 0.78786805 |
| 55 | KIT | 0.74775368 |
| 56 | TAOK2 | 0.74175116 |
| 57 | STK10 | 0.73877355 |
| 58 | EPHA3 | 0.71380581 |
| 59 | VRK1 | 0.69303936 |
| 60 | PDGFRB | 0.68504975 |
| 61 | FYN | 0.68292957 |
| 62 | MAP3K1 | 0.67500331 |
| 63 | MAPK12 | 0.66743955 |
| 64 | BMPR2 | 0.66109384 |
| 65 | HIPK2 | 0.64761581 |
| 66 | SCYL2 | 0.63415241 |
| 67 | LRRK2 | 0.62931442 |
| 68 | ERN1 | 0.57320539 |
| 69 | RET | 0.55284191 |
| 70 | SIK2 | 0.53513485 |
| 71 | PKN2 | 0.50975743 |
| 72 | PTK2B | 0.49237269 |
| 73 | MARK2 | 0.46152079 |
| 74 | CDK4 | 0.45556465 |
| 75 | IRAK3 | 0.45245834 |
| 76 | MAP3K5 | 0.44683767 |
| 77 | MAP2K6 | 0.44009477 |
| 78 | GRK5 | 0.41615969 |
| 79 | PDPK1 | 0.40244732 |
| 80 | MAPK7 | 0.38929090 |
| 81 | MAP3K10 | 0.36934305 |
| 82 | TGFBR2 | 0.36797700 |
| 83 | NEK6 | 0.35830002 |
| 84 | YES1 | 0.35281618 |
| 85 | MYLK | 0.33090787 |
| 86 | CLK1 | 0.30622301 |
| 87 | TLK1 | 0.30547177 |
| 88 | ADRBK2 | 0.29233965 |
| 89 | MAP3K7 | 0.29008486 |
| 90 | PIK3CA | 0.26398195 |
| 91 | MAPKAPK2 | 0.26353410 |
| 92 | PRKD1 | 0.25246290 |
| 93 | DYRK1B | 0.24624206 |
| 94 | IRAK2 | 0.24330378 |
| 95 | IGF1R | 0.24122501 |
| 96 | MAPK3 | 0.22547969 |
| 97 | INSR | 0.21131774 |
| 98 | TRIB3 | 0.20854654 |
| 99 | PRKD2 | 0.19535268 |
| 100 | KSR2 | 0.19184442 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.66902143 |
| 2 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 3.34379708 |
| 3 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.84689822 |
| 4 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.63743452 |
| 5 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.63464202 |
| 6 | Allograft rejection_Homo sapiens_hsa05330 | 2.62051262 |
| 7 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.52954501 |
| 8 | Measles_Homo sapiens_hsa05162 | 2.34335149 |
| 9 | Platelet activation_Homo sapiens_hsa04611 | 2.33869518 |
| 10 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.28924933 |
| 11 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.19678320 |
| 12 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.19177243 |
| 13 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.94755083 |
| 14 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.80833921 |
| 15 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.80830282 |
| 16 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.78173504 |
| 17 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.75998866 |
| 18 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.73904367 |
| 19 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.73181582 |
| 20 | Leishmaniasis_Homo sapiens_hsa05140 | 1.71603284 |
| 21 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.66279795 |
| 22 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.62205371 |
| 23 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.61403591 |
| 24 | Viral myocarditis_Homo sapiens_hsa05416 | 1.61241340 |
| 25 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.60815398 |
| 26 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.45756967 |
| 27 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.44107915 |
| 28 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.38563200 |
| 29 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.38390802 |
| 30 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.36275383 |
| 31 | Hepatitis B_Homo sapiens_hsa05161 | 1.35766703 |
| 32 | Malaria_Homo sapiens_hsa05144 | 1.35475222 |
| 33 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.34283305 |
| 34 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.19294789 |
| 35 | Shigellosis_Homo sapiens_hsa05131 | 1.18788428 |
| 36 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.18217414 |
| 37 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.16731870 |
| 38 | Tuberculosis_Homo sapiens_hsa05152 | 1.15098417 |
| 39 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.15041859 |
| 40 | Influenza A_Homo sapiens_hsa05164 | 1.14333950 |
| 41 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.13913294 |
| 42 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.10736523 |
| 43 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.08415629 |
| 44 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.07837236 |
| 45 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.04931951 |
| 46 | Asthma_Homo sapiens_hsa05310 | 1.04706204 |
| 47 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.96701747 |
| 48 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.94657151 |
| 49 | Apoptosis_Homo sapiens_hsa04210 | 0.89085293 |
| 50 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.86967339 |
| 51 | Colorectal cancer_Homo sapiens_hsa05210 | 0.86660220 |
| 52 | Hepatitis C_Homo sapiens_hsa05160 | 0.84404463 |
| 53 | Endocytosis_Homo sapiens_hsa04144 | 0.83115629 |
| 54 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.82819158 |
| 55 | Legionellosis_Homo sapiens_hsa05134 | 0.79057424 |
| 56 | HTLV-I infection_Homo sapiens_hsa05166 | 0.78219233 |
| 57 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.78037861 |
| 58 | Endometrial cancer_Homo sapiens_hsa05213 | 0.76881176 |
| 59 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.75509715 |
| 60 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.75426046 |
| 61 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.70662682 |
| 62 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.67053777 |
| 63 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.65736943 |
| 64 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.64272228 |
| 65 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.63417790 |
| 66 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.59538676 |
| 67 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.58958223 |
| 68 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.55918305 |
| 69 | Phagosome_Homo sapiens_hsa04145 | 0.54970693 |
| 70 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.54290316 |
| 71 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.52468694 |
| 72 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.51801748 |
| 73 | Salmonella infection_Homo sapiens_hsa05132 | 0.51603798 |
| 74 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.51299020 |
| 75 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.51269336 |
| 76 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.50463528 |
| 77 | Pertussis_Homo sapiens_hsa05133 | 0.45345106 |
| 78 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.45092007 |
| 79 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.43585859 |
| 80 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.42456465 |
| 81 | Thyroid cancer_Homo sapiens_hsa05216 | 0.41684479 |
| 82 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.40233721 |
| 83 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.39598752 |
| 84 | Prostate cancer_Homo sapiens_hsa05215 | 0.39266868 |
| 85 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.37075454 |
| 86 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.35712368 |
| 87 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.35643370 |
| 88 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.35456748 |
| 89 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.34085882 |
| 90 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.32125394 |
| 91 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.30971381 |
| 92 | Glioma_Homo sapiens_hsa05214 | 0.30370311 |
| 93 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.28758050 |
| 94 | Insulin resistance_Homo sapiens_hsa04931 | 0.28307297 |
| 95 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.27394845 |
| 96 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.26797269 |
| 97 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.25608037 |
| 98 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.23969942 |
| 99 | Long-term potentiation_Homo sapiens_hsa04720 | 0.22863518 |
| 100 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.22135657 |

